Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 325 to 328 of 328 entries
Sorted by: Best Match Show Resources per page
Simplifying Language Is Inclusive and Improves Access to Up-to-Date Scientific Information.

Disaster medicine and public health preparedness

Basch CH, Mohlman J, Hillyer GC, Garcia P.
PMID: 33766157
Disaster Med Public Health Prep. 2021 Mar 26;1. doi: 10.1017/dmp.2021.87. Epub 2021 Mar 26.

No abstract available.

Cite
Basch CH, Mohlman J, Hillyer GC, et al. Simplifying Language Is Inclusive and Improves Access to Up-to-Date Scientific Information. Disaster Med Public Health Prep. 2021;1doi: 10.1017/dmp.2021.87.
Basch, C. H., Mohlman, J., Hillyer, G. C., & Garcia, P. (2021). Simplifying Language Is Inclusive and Improves Access to Up-to-Date Scientific Information. Disaster medicine and public health preparedness, 1. https://doi.org/10.1017/dmp.2021.87
Basch, Corey H, et al. "Simplifying Language Is Inclusive and Improves Access to Up-to-Date Scientific Information." Disaster medicine and public health preparedness vol. (2021): 1. doi: https://doi.org/10.1017/dmp.2021.87
Basch CH, Mohlman J, Hillyer GC, Garcia P. Simplifying Language Is Inclusive and Improves Access to Up-to-Date Scientific Information. Disaster Med Public Health Prep. 2021 Mar 26;1. doi: 10.1017/dmp.2021.87. Epub 2021 Mar 26. PMID: 33766157; PMCID: PMC8167259.
Copy Download .nbib Format: NLM
Cholecystectomy 7 days vs 4 weeks after mild biliary pancreatitis; looking a decrease the incidence of persistent choledocholithiasis and ERCP: A multicentric randomized clinical trial.

International journal of surgery (London, England)

Facundo HG, Montoliu RR, Coronado Llanos DR, Naval GS, Millán EL, Gordo SL, Bosch JH, Rodríguez SL, Baranera MM, Martínez SG.
PMID: 34995805
Int J Surg. 2022 Jan 04;98:106207. doi: 10.1016/j.ijsu.2021.106207. Epub 2022 Jan 04.

BACKGROUND: Mild acute biliary pancreatitis (MABP) requires definitive treatment of the cholelithiasis to avoid recurrent biliary events. Recent publications recommend performing early surgery to prevent readmissions. However, an exceedingly early cholecystectomy could imply missing the presence of persistent choledocholithiasis...

Cite
Facundo HG, Montoliu RR, Coronado Llanos DR, et al. Cholecystectomy 7 days vs 4 weeks after mild biliary pancreatitis; looking a decrease the incidence of persistent choledocholithiasis and ERCP: A multicentric randomized clinical trial. Int J Surg. 2022;98:106207doi: 10.1016/j.ijsu.2021.106207.
Facundo, H. G., Montoliu, R. R., Coronado Llanos, D. R., Naval, G. S., Millán, E. L., Gordo, S. L., Bosch, J. H., Rodríguez, S. L., Baranera, M. M., & Martínez, S. G. (2022). Cholecystectomy 7 days vs 4 weeks after mild biliary pancreatitis; looking a decrease the incidence of persistent choledocholithiasis and ERCP: A multicentric randomized clinical trial. International journal of surgery (London, England), 98106207. https://doi.org/10.1016/j.ijsu.2021.106207
Facundo, Helena Gómez, et al. "Cholecystectomy 7 days vs 4 weeks after mild biliary pancreatitis; looking a decrease the incidence of persistent choledocholithiasis and ERCP: A multicentric randomized clinical trial." International journal of surgery (London, England) vol. 98 (2022): 106207. doi: https://doi.org/10.1016/j.ijsu.2021.106207
Facundo HG, Montoliu RR, Coronado Llanos DR, Naval GS, Millán EL, Gordo SL, Bosch JH, Rodríguez SL, Baranera MM, Martínez SG. Cholecystectomy 7 days vs 4 weeks after mild biliary pancreatitis; looking a decrease the incidence of persistent choledocholithiasis and ERCP: A multicentric randomized clinical trial. Int J Surg. 2022 Jan 04;98:106207. doi: 10.1016/j.ijsu.2021.106207. Epub 2022 Jan 04. PMID: 34995805.
Copy Download .nbib Format: NLM
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.

HemaSphere

Gaitzsch E, Passerini V, Khatamzas E, Strobl CD, Muenchhoff M, Scherer C, Osterman A, Heide M, Reischer A, Subklewe M, Leutbecher A, Tast B, Ruhle A, Weiglein T, Stecher SS, Stemmler HJ, Dreyling M, Girl P, Georgi E, Wölfel R, Mateyka L, D'Ippolito E, Schober K, Busch DH, Kager J, Spinner CD, Treiber M, Rasch S, Lahmer T, Iakoubov R, Schneider J, Protzer U, Winter C, Ruland J, Quante M, Keppler OT, von Bergwelt-Baildon M, Hellmuth J, Weigert O.
PMID: 34235400
Hemasphere. 2021 Jun 28;5(7):e603. doi: 10.1097/HS9.0000000000000603. eCollection 2021 Jul.

The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas....

Cite
Gaitzsch E, Passerini V, Khatamzas E, et al. COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma. Hemasphere. 2021;5(7):e603doi: 10.1097/HS9.0000000000000603.
Gaitzsch, E., Passerini, V., Khatamzas, E., Strobl, C. D., Muenchhoff, M., Scherer, C., Osterman, A., Heide, M., Reischer, A., Subklewe, M., Leutbecher, A., Tast, B., Ruhle, A., Weiglein, T., Stecher, S. S., Stemmler, H. J., Dreyling, M., Girl, P., Georgi, E., Wölfel, R., Mateyka, L., D'Ippolito, E., Schober, K., Busch, D. H., Kager, J., Spinner, C. D., Treiber, M., Rasch, S., Lahmer, T., Iakoubov, R., Schneider, J., Protzer, U., Winter, C., Ruland, J., Quante, M., Keppler, O. T., von Bergwelt-Baildon, M., Hellmuth, J., & Weigert, O. (2021). COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma. HemaSphere, 5(7), e603. https://doi.org/10.1097/HS9.0000000000000603
Gaitzsch, Erik, et al. "COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma." HemaSphere vol. 5,7 (2021): e603. doi: https://doi.org/10.1097/HS9.0000000000000603
Gaitzsch E, Passerini V, Khatamzas E, Strobl CD, Muenchhoff M, Scherer C, Osterman A, Heide M, Reischer A, Subklewe M, Leutbecher A, Tast B, Ruhle A, Weiglein T, Stecher SS, Stemmler HJ, Dreyling M, Girl P, Georgi E, Wölfel R, Mateyka L, D'Ippolito E, Schober K, Busch DH, Kager J, Spinner CD, Treiber M, Rasch S, Lahmer T, Iakoubov R, Schneider J, Protzer U, Winter C, Ruland J, Quante M, Keppler OT, von Bergwelt-Baildon M, Hellmuth J, Weigert O. COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma. Hemasphere. 2021 Jun 28;5(7):e603. doi: 10.1097/HS9.0000000000000603. eCollection 2021 Jul. PMID: 34235400; PMCID: PMC8240782.
Copy Download .nbib Format: NLM
A Single-Cell Perspective on Memory T-Cell Differentiation.

Cold Spring Harbor perspectives in biology

Kretschmer L, Busch DH, Buchholz VR.
PMID: 33903160
Cold Spring Harb Perspect Biol. 2021 Sep 01;13(9). doi: 10.1101/cshperspect.a038067.

Memory differentiation of CD4 and CD8 T-cell populations has been extensively studied and many key molecular players and transcriptional networks have been identified. But how regulatory principles, identified on this population level, translate to immune responses that originate from...

Cite
Kretschmer L, Busch DH, Buchholz VR. A Single-Cell Perspective on Memory T-Cell Differentiation. Cold Spring Harb Perspect Biol. 2021;13(9)doi: 10.1101/cshperspect.a038067.
Kretschmer, L., Busch, D. H., & Buchholz, V. R. (2021). A Single-Cell Perspective on Memory T-Cell Differentiation. Cold Spring Harbor perspectives in biology, 13(9), . https://doi.org/10.1101/cshperspect.a038067
Kretschmer, Lorenz, et al. "A Single-Cell Perspective on Memory T-Cell Differentiation." Cold Spring Harbor perspectives in biology vol. 13,9 (2021). doi: https://doi.org/10.1101/cshperspect.a038067
Kretschmer L, Busch DH, Buchholz VR. A Single-Cell Perspective on Memory T-Cell Differentiation. Cold Spring Harb Perspect Biol. 2021 Sep 01;13(9). doi: 10.1101/cshperspect.a038067. PMID: 33903160; PMCID: PMC8411955.
Copy Download .nbib Format: NLM
Showing 325 to 328 of 328 entries